[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369658-105":59,"doc-detail-369658-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","msh6-as-a-prognostic-biomarker-in-bladder-cancer-and-its-correlation-with-immunity","MSH6 as a prognostic biomarker in bladder cancer and its correlation with immunity","","Study investigates the role of MSH6 in bladder cancer diagnosis and prognosis and its association with immune responses. Analyses are conducted on TCGA datasets and validated using GEO. Molecular mechanisms are explored with R-based methods including GSEA and Gene Ontology, supported by clinical cohort tissue validation. Immunohistochemistry shows higher MSH6 expression in tumors than adjacent tissue. High MSH6 independently predicts worse overall survival. Cell knockdown experiments demonstrate reduced proliferation, colony formation, and migration, linking MSH6 to tumor immune microenvironment and potential immunotherapy relevance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/msh6-as-a-prognostic-biomarker-in-bladder-cancer-and-its-correlation-with-immunity/369658/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/msh6-as-a-prognostic-biomarker-in-bladder-cancer-and-its-correlation-with-immunity/369658.png","ImageObject",300,407,{"name":92,"@type":93},"Đào","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research goal of this study?","Question",{"text":112,"@type":113},"To determine how MSH6 relates to bladder cancer diagnosis and prognosis and how it correlates with immunity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was MSH6 expression validated in the study?",{"text":117,"@type":113},"MSH6 expression was analyzed using TCGA data and validated for protein expression using the Human Protein Atlas (HPA) and further validation through GEO.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the study report about MSH6’s prognostic value?",{"text":121,"@type":113},"Higher MSH6 expression is associated with poorer overall survival and is identified as an independent prognostic factor for bladder cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369658,1790876527,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nMSH6 as a prognostic biomarker in bladder cancer and its correlation with immunity  \nNing He1,5, Lu-ri Bao2,5, Peng-cheng Ma4,5, Zhen-li Fu1, Wu-niri Gao4, Jing-yuan Wang2, Li-Gang Chen3 & Yan Meng4􀀍  \nThis study aims to investigate the role of MSH6 in the diagnosis and prognosis of bladder cancer and its association with immunity. Various analyses were conducted on The Cancer Genome Atlas (TCGA) data, and the results were validated using the Gene Expression Omnibus (GEO) database. The potential mechanism of MSH6 in bladder cancer was revealed using R tools, Gene Set Enrichment Analysis (GSEA), and Gene Ontology (GO) analysis. Bladder cancer patients admitted to the Affiliated Hospital of Inner Mongolia Medical University from June 2023 to December 2023 were enrolled. Pathological specimens of bladder cancer and adjacent tissues were obtained. Immunohistochemical results showed the expression of MSH6 in bladder cancer tissues was higher than in adjacent tissues. High expression of MSH6 was identified as an independent prognostic factor for bladder cancer. The occurrence of bladder cancer was also influenced by age, pathological T stage, and pathological stage. According to the Kaplan–Meier survival curve, the overall survival rate of the MSH6 high-expression group was lower (P = 0.004). After MSH6 was knocked down in cell experiments, the proliferation, colony formation, and migration abilities of bladder cancer cells were significantly inhibited. MSH6 is significantly associated with the diagnosis and prognosis of bladder cancer, suggesting its potential utility as a biomarker for these purposes. MSH6 is closely related to the tumor immune microenvironment, implying a significant role in immunotherapy.  \nKeywords Bladder cancer, Bladder urothelial carcinoma, MSH6, Biomarkers, Immunization  \nAbbreviations  \nTCGA The Cancer Genome Atlas  \nBLCA Bladder cancer  \nGEO Gene Expression Omnibus  \nGSEA Gene Set Enrichment Analysis  \nGO Gene Ontology  \nHPA Human Protein Atlas  \nOS Overall survival  \nROC Receiver operating characteristic  \nAUC Area under the curve  \nAOD Average optical density BP Biological process  \nMF Molecular function  \nCC Cellular component  \nBP Biological process  \nMF Molecular function  \nCAN Copy number alteration  \nK‒M Kaplan–Meier survival curve  \nsiRNA Small interfering RNA  \n1Department of Hemodialysis, The No. 2 Hospital of Hohhot, Hohhot, People’s Republic of China. 2Department of Pathology, School of Basic Medicine, Inner Mongolia Medical University, Hohhot, People’s Republic of China.  \n3Department of Urology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, People’s Republic of China. 4Department of Nephrology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, Inner Mongolia, People’s Republic of China. 5Ning He, Lu-ri Bao and Peng-cheng Ma contributed equally to this article. 􀀍 email: [mbao124@qq.com](mbao124@qq.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nTreg Th1 cells aDC Th2 cells Tfh  \nTem  \npDC NK cells Th17 cells  \nRegulatory T cells  \nType 1 Th cells  \nActivated dendritic cells Type 2 Th cells T follicular helper T effector memory Plasmacytoid dendritic cell Natural killer cells  \nType 17 Th cells  \nBladder cancer remains the most common malignant tumor of the urinary system. In 2018, 549,393 individuals were diagnosed with bladder cancer, and 199,922 deaths were recorded worldwide1. The most common pathological type of bladder cancer is urothelial carcinoma, accounting for 90% of all cases. Other types, including squamous cell carcinoma and adenocarcinoma, account for approximately 10%2. At diagnosis, 75% of bladder cancers are confined to the mucosal urothelium and are classified as non-muscle-invasive diseases. In the remaining 25–30% of patients, bladder cancer invade the deep layer of the bladder wall or metastasize3. Therefore, ","cbCaiiO0Q0w6Citf","https://ap.wps.com/l/cbCaiiO0Q0w6Citf","pdf",7006368,15,"English","# Introduction\n## Background on bladder cancer and mismatch repair\n## Rationale for investigating MSH6\n# Methods\n## TCGA and HPA analysis\n## GEO validation and R-based analyses\n## GSEA/GO and tumor microenvironment assessment\n## Nomogram and ROC evaluation\n## Genetic alteration analysis\n# Results\n## MSH6 expression pattern in tissues\n## Prognostic value and survival association\n## Effects of MSH6 knockdown on cell behavior\n## Links to immune microenvironment","[{\"question\":\"What is the main research goal of this study?\",\"answer\":\"To determine how MSH6 relates to bladder cancer diagnosis and prognosis and how it correlates with immunity.\"},{\"question\":\"How was MSH6 expression validated in the study?\",\"answer\":\"MSH6 expression was analyzed using TCGA data and validated for protein expression using the Human Protein Atlas (HPA) and further validation through GEO.\"},{\"question\":\"What does the study report about MSH6’s prognostic value?\",\"answer\":\"Higher MSH6 expression is associated with poorer overall survival and is identified as an independent prognostic factor for bladder cancer.\"}]","MSH6 as a prognostic biomarker in bladder cancer and its correlation with immunity | PDF",1790183952,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01e3d8c4ecbcb0e66048016f333a5bca.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64b068bab954a66cdd155a22d38c8d6f.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a07ea1d7b0a7647c74a4a11f5ebcc6c.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d699252b1130862577bfacfd0970c7b.webp",980,1287]